Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient age.
Puig
J M
JM
Department of Nephrology, Hospital del Mar, Barcelona, Spain.
Fernández-Crespo
P
P
Lloveras
J
J
Mir
M
M
Iñigo
V
V
Manresa
J M
JM
Masramón
J
J
D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria; D006435:Renal Dialysis; D012086:Reoperation; D012307:Risk Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid; D011241:Prednisone